Coronary artery calcium (CAC) scoring is an important method for cardiovascular risk assessment. While artificial intelligence (AI) has been applied to automate CAC scoring in calcium scoring computed tomography (CSCT), its application to low-dose computed tomography (LDCT) scans, typically used for lung cancer screening, remains challenging due to the lower image quality and higher noise levels of LDCT. This study presents a diffusion model-based method for converting LDCT to CSCT images with the aim of improving CAC scoring accuracy from LDCT scans. A conditional diffusion model was developed to generate CSCT images from LDCT by modifying the denoising diffusion implicit model (DDIM) sampling process. Two main modifications were introduced: (1) random pointing, a novel sampling technique that enhances the trajectory guidance methodology of DDIM using stochastic Gaussian noise to optimize domain adaptation, and (2) intermediate sampling, an advanced methodology that strategically injects minimal noise into LDCT images prior to sampling to maximize structural preservation. The model was trained on LDCT and CSCT images obtained from the same patients but acquired separately at different time points and patient positions, and validated on 37 test cases. The proposed method showed superior performance compared to widely used image-to-image models (CycleGAN, CUT, DCLGAN, NEGCUT) across several evaluation metrics, including peak signal-to-noise ratio (39.93 ± 0.44), Local Normalized Cross-Correlation (0.97 ± 0.01), structural similarity index (0.97 ± 0.01), and Dice similarity coefficient (0.73 ± 0.10). The modifications to the sampling process reduced the number of iterations from 1000 to 10 while maintaining image quality. Volumetric analysis indicated a stronger correlation between the calcium volumes in the enhanced CSCT images and expert-verified annotations, as compared to the original LDCT images. The proposed method effectively transforms LDCT images to CSCT images while preserving anatomical structures and calcium deposits. The reduction in sampling time and the improved preservation of calcium structures suggest that the method could be applicable for clinical use in cardiovascular risk assessment.

The Segment Anything Model (SAM) was fine-tuned on the EchoNet-Dynamic dataset and evaluated on external transthoracic echocardiography (TTE) and Point-of-Care Ultrasound (POCUS) datasets from CAMUS (University Hospital of St Etienne) and Mayo Clinic (99 patients: 58 TTE, 41 POCUS). Fine-tuned SAM was superior or comparable to MedSAM. The fine-tuned SAM also outperformed EchoNet and U-Net models, demonstrating strong generalization, especially on apical 2-chamber (A2C) images (fine-tuned SAM vs. EchoNet: CAMUS-A2C: DSC 0.891 ± 0.040 vs. 0.752 ± 0.196, p < 0.0001) and POCUS (DSC 0.857 ± 0.047 vs. 0.667 ± 0.279, p < 0.0001). Additionally, SAM-enhanced workflow reduced annotation time by 50% (11.6 ± 4.5 sec vs. 5.7 ± 1.7 sec, p < 0.0001) while maintaining segmentation quality. We demonstrated an effective strategy for fine-tuning a vision foundation model for enhancing clinical workflow efficiency and supporting human-AI collaboration.

This study aims to evaluate the predictive value of multiparameter characteristics of coronary computed tomography angiography (CCTA) plaque and the ratio of coronary artery volume to myocardial mass (V/M) in guiding percutaneous coronary stent implantation (PCI) in patients diagnosed with unstable angina. Patients who underwent CCTA and coronary angiography (CAG) within 2 months were retrospectively analyzed. According to CAG results, patients were divided into a medical therapy group (n=41) and a PCI revascularization group (n=37). The plaque characteristics and V/M were quantitatively evaluated. The parameters included minimum lumen area at stenosis (MLA), maximum area stenosis (MAS), maximum diameter stenosis (MDS), total plaque burden (TPB), plaque length, plaque volume, and each component volume within the plaque. Fractional flow reserve (FFR) and pericoronary fat attenuation index (FAI) were calculated based on CCTA. Artificial intelligence software was employed to compare the differences in each parameter between the 2 groups at both the vessel and plaque levels. The PCI group had higher MAS, MDS, TPB, FAI, noncalcified plaque volume and lipid plaque volume, and significantly lower V/M, MLA, and CT-derived fractional flow reserve (FFRCT). V/M, TPB, MLA, FFRCT, and FAI are important influencing factors of PCI. The combined model of MLA, FFRCT, and FAI had the largest area under the ROC curve (AUC=0.920), and had the best performance in predicting PCI. The integration of AI-derived multiparameter features from one-stop CCTA significantly enhances the accuracy of predicting PCI in angina pectoris patients, evaluating at the plaque, vessel, and patient levels.

Congenital heart defect (CHD) is a significant, rapidly emerging global problem in child health and a leading cause of neonatal and childhood death. Prenatal detection of CHDs with the help of ultrasound allows better perinatal management of such pregnancies, leading to reduced neonatal mortality, morbidity and developmental complications. However, there is a wide variation in reported fetal heart problem detection rates from 34% to 85%, with some low- and middle-income countries detecting as low as 9.3% of cases before birth. Research has shown that deep learning-based or more general artificial intelligence (AI) models can support the detection of fetal CHDs more rapidly than humans performing ultrasound scan. Progress in this AI-based research depends on the availability of large, well-curated and diverse data of ultrasound images and videos of normal and abnormal fetal hearts. Currently, CHD detection based on AI models is not accurate enough for practical clinical use, in part due to the lack of ultrasound data available for machine learning as CHDs are rare and heterogeneous, the retrospective nature of published studies, the lack of multicentre and multidisciplinary collaboration, and utilisation of mostly standard planes still images of the fetal heart for AI models. Our aim is to develop AI models that could support clinicians in detecting fetal CHDs in real time, particularly in nonspecialist or low-resource settings where fetal echocardiography expertise is not readily available. We have designed the Clinical Artificial Intelligence Fetal Echocardiography (CAIFE) study as an international multicentre multidisciplinary collaboration led by a clinical and an engineering team at the University of Oxford. This study involves five multicountry hospital sites for data collection (Oxford, UK (n=1), London, UK (n=3) and Southport, Australia (n=1)). We plan to curate 14 000 retrospective ultrasound scans of fetuses with normal hearts (n=13 000) and fetuses with CHDs (n=1000), as well as 2400 prospective ultrasound cardiac scans, including the proposed research-specific CAIFE 10 s video sweeps, from fetuses with normal hearts (n=2000) and fetuses diagnosed with major CHDs (n=400). This gives a total of 16 400 retrospective and prospective ultrasound scans from the participating hospital sites. We will build, train and validate computational models capable of differentiating between normal fetal hearts and those diagnosed with CHDs and recognise specific types of CHDs. Data will be analysed using statistical metrics, namely, sensitivity, specificity and accuracy, which include calculating positive and negative predictive values for each outcome, compared with manual assessment. We will disseminate the findings through regional, national and international conferences and through peer-reviewed journals. The study was approved by the Health Research Authority, Care Research Wales and the Research Ethics Committee (Ref: 23/EM/0023; IRAS Project ID: 317510) on 8 March 2023. All collaborating hospitals have obtained the local trust research and development approvals.

Although genetic variant effects often interact nonadditively, strategies to uncover epistasis remain in their infancy. Here we develop low-signal signed iterative random forests to elucidate the complex genetic architecture of cardiac hypertrophy, using deep learning-derived left ventricular mass estimates from 29,661 UK Biobank cardiac magnetic resonance images. We report epistatic variants near CCDC141, IGF1R, TTN and TNKS, identifying loci deemed insignificant in genome-wide association studies. Functional genomic and integrative enrichment analyses reveal that genes mapped from these loci share biological process gene ontologies and myogenic regulatory factors. Transcriptomic network analyses using 313 human hearts demonstrate strong co-expression correlations among these genes in healthy hearts, with significantly reduced connectivity in failing hearts. To assess causality, RNA silencing in human induced pluripotent stem cell-derived cardiomyocytes, combined with novel microfluidic single-cell morphology analysis, confirms that cardiomyocyte hypertrophy is nonadditively modifiable by interactions between CCDC141, TTN and IGF1R. Our results expand the scope of cardiac genetic regulation to epistasis.

Computed tomography is an inadequate method for detecting myocardial focal scar (MFS) due to its moderate density resolution, which is insufficient for distinguishing MFS from artificial beam-hardening (BH). Virtual monochromatic images (VMIs) of dual-energy coronary computed tomography angiography (DECCTA) provide a variety of diagnostic information with significant potential for detecting myocardial lesions. The aim of this study was to assess whether radiomics analysis in VMIs of DECCTA can help distinguish MFS from BH. A prospective cohort of patients who were suspected with an old myocardial infarction was assembled at two different centers between Janurary 2021 and June 2024. MFS and BH segmentation and radiomics feature extraction and selection were performed on VMIs images, and four machine learning classifiers were constructed using selected strongest features. Subsequently, an independent validation was conducted, and a subjective diagnosis of the validation set was provided by an radiologist. The AUC was used to assess the performance of the radiomics models. The training set included 57 patients from center 1 (mean age, 54 years +/- 9, 55 men), and the external validation set included 10 patients from center 2 (mean age, 59 years +/- 10, 9 men). The radiomics models exhibited the highest AUC value of 0.937 (expressed at 130 keV VMIs), while the radiologist demonstrated the highest AUC value of 0.734 (expressed at 40 keV VMIs). The integration of radiomic features derived from VMIs of DECCTA with machine learning algorithms has the potential to improve the efficiency of distinguishing MFS from BH.

Cardiac amyloidosis is associated with poor outcomes and is caused by the interstitial deposition of misfolded proteins, typically ATTR (transthyretin) or AL (light chains). Although specific therapies during early disease stages exist, the diagnosis is often only established at an advanced stage. Cardiovascular magnetic resonance (CMR) is the gold standard for imaging suspected myocardial disease. However, differentiating cardiac amyloidosis from hypertrophic cardiomyopathy may be challenging, and a reliable method for an image-based classification of amyloidosis subtypes is lacking. This study sought to investigate a CMR machine learning (ML) algorithm to identify and distinguish cardiac amyloidosis. This retrospective, multicenter, multivendor feasibility study included consecutive patients diagnosed with hypertrophic cardiomyopathy or AL/ATTR amyloidosis and healthy volunteers. Standard clinical information, semiautomated CMR imaging data, and qualitative CMR features were integrated into a trained ML algorithm. Four hundred participants (95 healthy, 94 hypertrophic cardiomyopathy, 95 AL, and 116 ATTR) from 56 institutions were included (269 men aged 58.5 [48.4-69.4] years). A 3-stage ML screening cascade sequentially differentiated healthy volunteers from patients, then hypertrophic cardiomyopathy from amyloidosis, and then AL from ATTR. The ML algorithm resulted in an accurate differentiation at each step (area under the curve, 1.0, 0.99, and 0.92, respectively). After reducing included data to demographics and imaging data alone, the performance remained excellent (area under the curve, 0.99, 0.98, and 0.88, respectively), even after removing late gadolinium enhancement imaging data from the model (area under the curve, 1.0, 0.95, 0.86, respectively). A trained ML model using semiautomated CMR imaging data and patient demographics can accurately identify cardiac amyloidosis and differentiate subtypes.

Left ventricular non-compaction is a cardiac condition marked by excessive trabeculae in the left ventricle's inner wall. Although various methods exist to measure these structures, the medical community still lacks consensus on the best approach. Previously, we developed DL-LVTQ, a tool based on a UNet neural network, to quantify trabeculae in this region. In this study, we expand the dataset to include new patients with Titin cardiomyopathy and healthy individuals with fewer trabeculae, requiring retraining of our models to enhance predictions. We also propose ViTUNeT, a neural network architecture combining U-Net and Vision Transformers to segment the left ventricle more accurately. Additionally, we train a YOLOv8 model to detect the ventricle and integrate it with ViTUNeT model to focus on the region of interest. Results from ViTUNet and YOLOv8 are similar to DL-LVTQ, suggesting dataset quality limits further accuracy improvements. To test this, we analyze MRI images and develop a method using two YOLOv8 models to identify and remove problematic images, leading to better results. Combining YOLOv8 with deep learning networks offers a promising approach for improving cardiac image analysis and segmentation.

<b>BACKGROUND.</b> The importance of including the thoracic aortic calcification (TAC), in addition to coronary artery calcification (CAC), in prognostic assessments has been difficult to determine, partly due to greater challenge in performing standardized TAC assessments. <b>OBJECTIVE.</b> The purpose of this study was to evaluate long-term prognostic implications of TAC assessed using artificial intelligence (AI)-based quantification on routine chest CT in a screening population. <b>METHODS.</b> This retrospective study included 7404 asymptomatic individuals (median age, 53.9 years; 5875 men, 1529 women) who underwent nongated noncontrast chest CT as part of a national general health screening program at one of two centers from January 2007 to December 2014. A commercial AI program quantified TAC and CAC using Agatston scores, which were stratified into categories. Radiologists manually quantified TAC and CAC in 2567 examinations. The role of AI-based TAC categories in predicting major adverse cardiovascular events (MACE) and all-cause mortality (ACM), independent of AI-based CAC categories as well as clinical and laboratory variables, was assessed by multivariable Cox proportional hazards models using data from both centers and concordance statistics from prognostic models developed and tested using center 1 and center 2 data, respectively. <b>RESULTS.</b> AI-based and manual quantification showed excellent agreement for TAC and CAC (concordance correlation coefficient: 0.967 and 0.895, respectively). The median observation periods were 7.5 years for MACE (383 events in 5342 individuals) and 11.0 years for ACM (292 events in 7404 individuals). When adjusted for AI-based CAC categories along with clinical and laboratory variables, the risk for MACE was not independently associated with any AI-based TAC category; risk of ACM was independently associated with AI-based TAC score of 1001-3000 (HR = 2.14, <i>p</i> = .02) but not with other AI-based TAC categories. When prognostic models were tested, the addition of AI-based TAC categories did not improve model fit relative to models containing clinical variables, laboratory variables, and AI-based CAC categories for MACE (concordance index [C-index] = 0.760-0.760, <i>p</i> = .81) or ACM (C-index = 0.823-0.830, <i>p</i> = .32). <b>CONCLUSION.</b> The addition of TAC to models containing CAC provided limited improvement in risk prediction in an asymptomatic screening population undergoing CT. <b>CLINICAL IMPACT.</b> AI-based quantification provides a standardized approach for better understanding the potential role of TAC as a predictive imaging biomarker.

Recent advancements in artificial intelligence (AI) have revolutionized cardiovascular medicine, particularly through integration with computed tomography (CT), magnetic resonance imaging (MRI), electrocardiography (ECG) and ultrasound (US). Deep learning architectures, including convolutional neural networks and generative adversarial networks, enable automated analysis of medical imaging and physiological signals, surpassing human capabilities in diagnostic accuracy and workflow efficiency. However, critical challenges persist, including the inability to validate input data accuracy, which may propagate diagnostic errors. This review highlights AI's transformative potential in precision diagnostics while underscoring the need for robust validation protocols to ensure clinical reliability. Future directions emphasize hybrid models integrating multimodal data and adaptive algorithms to refine personalized cardiovascular care.